Additionally, the distribution of the most frequently mutated genes in gliomas within ERI subgroups was scrutinized, revealing a higher prevalence of TP53 and EGFR mutations in high-ERI subgroups (Supplementary Figure 2C). This evidence concerns the gene EGFR and glioma.